News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,629 Results
Type
Article (14240)
Company Profile (282)
Press Release (252107)
Section
Business (79536)
Career Advice (153)
Deals (13228)
Drug Delivery (36)
Drug Development (50459)
Employer Resources (31)
FDA (5722)
Job Trends (5137)
News (144453)
Policy (10039)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21643)
ALS (60)
Alzheimer's disease (825)
Antibody-drug conjugate (ADC) (86)
Approvals (5735)
Artificial intelligence (106)
Autoimmune disease (10)
Automation (5)
Bankruptcy (104)
Best Places to Work (4570)
BIOSECURE Act (5)
Biosimilars (39)
Biotechnology (232)
Bladder cancer (43)
Brain cancer (19)
Breast cancer (139)
Cancer (1277)
Cardiovascular disease (100)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (304)
Cervical cancer (7)
Clinical research (40855)
Collaboration (494)
Compensation (218)
Complete response letters (13)
COVID-19 (1036)
CRISPR (36)
C-suite (141)
Cystic fibrosis (76)
Data (1328)
Denatured (11)
Depression (28)
Diabetes (122)
Diagnostics (1292)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (76)
Drug pricing (28)
Drug shortages (4)
Duchenne muscular dystrophy (81)
Earnings (29617)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48098)
Executive appointments (396)
FDA (6332)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (462)
Gene editing (87)
Generative AI (9)
Gene therapy (226)
GLP-1 (353)
Government (1074)
Grass and pollen (2)
Guidances (18)
Healthcare (6604)
Huntington's disease (21)
IgA nephropathy (20)
Immunology and inflammation (78)
Indications (18)
Infectious disease (1097)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (55)
Interviews (17)
IPO (7265)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (199)
Leadership (2)
Legal (1390)
Liver cancer (30)
Lung cancer (183)
Lymphoma (81)
Machine learning (1)
Management (7)
Manufacturing (115)
MASH (47)
Medical device (2598)
Medtech (2599)
Mergers & acquisitions (6247)
Metabolic disorders (358)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (57)
Neuropsychiatric disorders (23)
Neuroscience (1186)
NextGen: Class of 2025 (2021)
Non-profit (853)
Northern California (1522)
Now hiring (21)
Obesity (183)
Opinion (100)
Ovarian cancer (59)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (102)
Partnered (6)
Patents (108)
Patient recruitment (66)
Peanut (35)
People (25500)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14425)
Phase II (19010)
Phase III (12016)
Pipeline (665)
Podcasts (46)
Policy (35)
Postmarket research (854)
Preclinical (6064)
Press Release (30)
Prostate cancer (51)
Psychedelics (35)
Radiopharmaceuticals (211)
Rare diseases (270)
Real estate (1414)
Recruiting (12)
Regulatory (8554)
Reports (15)
Research institute (943)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (91)
Series B (59)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1354)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1973)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (33)
United States (11947)
Vaccines (204)
Venture capitalists (28)
Webinars (7)
Weight loss (104)
Women's health (15)
Worklife (2)
Date
Today (80)
Last 7 days (344)
Last 30 days (1682)
Last 365 days (20052)
2025 (4522)
2024 (20562)
2023 (22423)
2022 (26846)
2021 (27825)
2020 (23377)
2019 (16260)
2018 (11752)
2017 (13758)
2016 (11849)
2015 (14369)
2014 (10407)
2013 (7493)
2012 (7546)
2011 (7626)
2010 (7434)
Location
Africa (150)
Alabama (38)
Alaska (2)
Arizona (52)
Arkansas (5)
Asia (17213)
Australia (2917)
California (3471)
Canada (1042)
China (319)
Colorado (134)
Connecticut (141)
Delaware (87)
Europe (37056)
Florida (408)
Georgia (106)
Idaho (16)
Illinois (209)
India (8)
Indiana (85)
Iowa (1)
Japan (66)
Kansas (59)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (440)
Massachusetts (2734)
Michigan (69)
Minnesota (134)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (869)
New Mexico (12)
New York (947)
North Carolina (516)
North Dakota (4)
Northern California (1522)
Ohio (108)
Oklahoma (9)
Oregon (21)
Pennsylvania (662)
Puerto Rico (3)
Rhode Island (14)
South America (208)
South Carolina (4)
Southern California (1354)
Tennessee (25)
Texas (393)
Utah (48)
Virginia (67)
Washington D.C. (28)
Washington State (316)
Wisconsin (13)
266,629 Results for "achilles therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
December 24, 2024
·
4 min read
Press Releases
Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
November 19, 2024
·
3 min read
Press Releases
Achilles Therapeutics Announces Strategic Update
September 19, 2024
·
6 min read
Press Releases
Achilles Therapeutics Reports Third Quarter 2024 Financial Results
November 15, 2024
·
5 min read
Business
Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Achilles Therapeutics plc announced its financial results for the first quarter ended March 31, 2024, and recent business highlights.
May 8, 2024
·
7 min read
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines
Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced a research collaboration with Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), an mRNA medicines company, to evaluate best-in-class, self-amplifying mRNA (sa-mRNA) personalized cancer vaccines (PCVs) targeting clonal neoantigens.
May 22, 2024
·
8 min read
Business
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
Achilles Therapeutics plc announced its financial results for the fourth quarter and year-ended December 31, 2023, and recent business highlights.
April 4, 2024
·
9 min read
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - May 17, 2024
Achilles Therapeutics plc disclosed that the Company received notice on May 16, 2024 from the Nasdaq Stock Market LLC that the Company is not currently in compliance with the $1.00 minimum bid price requirement for continued listing of the Company’s American Depositary Shares on the Nasdaq Global Select Market, as set forth in Nasdaq Listing Rule 5450.
May 17, 2024
·
3 min read
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal neoantigens to treat solid tumors, today announced that the Company will be presenting at the following conference.
February 5, 2024
·
1 min read
Press Releases
Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates
August 14, 2024
·
8 min read
1 of 26,663
Next
